Page 2 - Representative Actions News Today

Draft consumer protection bill raises concerns about a number of the provisions, particularly the high costs involved in taking a court case

As we ring in the new year, it is time once again to reflect on some of the most significant legal developments for drug and device companies this year. The list below is by no means...

This article provides a rundown of key considerations before bringing claims relating to complex commercial disputes in Netherlands.

The Federal Food, Drug, and Cosmetic Act (FDCA) and the Public Health Service Act (PHSA) are the two key statutes governing the development, manufacturing, distribution, registration, licensing, clearance...

The US Securities and Exchange Commission (SEC) has adopted a new standard called Regulation Best Interest (Reg BI) that shifts the focus on protecting customers first and foremost....

Draft legislation introduced in Ireland could drive an increase in mass consumer claims and have an impact on financial services firms in particular, though a complete shift to a US-style system of opt out class actions has not been proposed.

For more than twenty years, the European Union (EU) witnessed the development of collective redress mechanisms to address mass claims situations. To ensure the proper implementation of...

MEPs’ joint report on European Artificial Intelligence Act sets out limited ban on predictive policing systems alongside a raft of further amendments to improve redress mechanisms and extend the list of AI systems deemed high-risk.

In this sixth alert in our series regarding the European Parliament’s formal endorsement of a new collective actions legislation titled the Directive of the European Parliament and of...

With Directive (EU) 2020/1828 on representative actions for the protection of the collective interests of consumers and repealing Directive 2009/22/EC (“the Representative Actions...